CVS To Pay $36.7M To Settle Whistleblower Claims

Law360, New York (March 18, 2008, 12:00 AM EDT) -- CVS Caremark Corp. has agreed to pay $36.7 million to settle claims that the retail pharmacy giant switched patients to a more expensive version of the prescription drug ranitidine in order to gain increased Medicaid reimbursements.

Under the agreement announced Tuesday, Woonsocket, R.I.-based CVS will pay $21.1 million to the U.S. government, plus another $15.6 million to the District of Columbia and the 23 states that brought their own claims against the company, the U.S. Department of Justice said.

Licensed pharmacist Bernard Listiza, the whistleblower in...
To view the full article, register now.